Skip to main content

Table 3 Cumulative survival rates of patients in which the 4 lung cancer resection guidelines were or were not followed

From: Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

  1-year 3-year 5-year P
Overall 0.86 (0.84, 0.87) 0.60 (0.58, 0.62) 0.45 (0.42, 0.47)  
IASLC guidelines     <0.001*
 Yes 0.90 (0.88, 0.92) 0.69 (0.66, 0.71) 0.51 (0.48, 0.54)  
 No 0.85 (0.84, 0.87) 0.53 (0.58, 0.58) 0.41 (0.38, 0.44)  
ACOSOG guidelines     <0.001*
 Yes 0.88 (0.86, 0.9) 0.64 (0.61, 0.66) 0.47 (0.44, 0.49)  
 No 0.82 (0.79, 0.84) 0.55 (0.52, 0.58) 0.42 (0.38, 0.45)  
RADIANT guidelines     <0.001*
 Yes 0.88 (0.86, 0.89) 0.62 (0.6, 0.64) 0.46 (0.43, 0.49)  
 No 0.79 (0.75, 0.82) 0.53 (0.49, 0.57) 0.40 (0.35, 0.44)  
NCCN guidelines     <0.001*
 Yes 0.88 (0.86, 0.90) 0.64 (0.61, 0.66) 0.47 (0.44, 0.49)  
 No 0.82 (0.79, 0.84) 0.55 (0.52, 0.58) 0.42 (0.38, 0.45)  
  1. ACOSOG, American College of Surgeons Oncology Group; IASLC, International Association for the Study of Lung Cancer (IASLC); NCCN, National Comprehensive Cancer Network; RADIANT, OSI Pharmaceutical’s RADIANT study; CI, confidence interval.
  2. Results are presented as cumulative survival rate (0.0-1.0) with corresponding 95% CI.
  3. *Significant difference between Yes/No follow guidelines, P < 0.05.